Loading…
Tenaya Therapeutics, Inc. is projected to rise to $0.8367 by 2027, a +13% move from its current price of $0.7403. TNYA is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 4 | $0.7201 | $0.7403 | $0.7609 | 0.00% |
| Aug 5 | $0.7119 | $0.7402 | $0.7696 | -0.01% |
| Aug 6 | $0.7057 | $0.7402 | $0.7764 | -0.01% |
| Aug 7 | $0.7005 | $0.7402 | $0.7821 | -0.02% |
| Aug 8 | $0.6959 | $0.7401 | $0.7872 | -0.02% |
| Aug 9 | $0.6918 | $0.7401 | $0.7918 | -0.03% |
| Aug 10 | $0.688 | $0.74 | $0.796 | -0.03% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.688 | $0.74 | $0.796 | -0.03% |
| Week 2 | $0.6673 | $0.7398 | $0.8201 | -0.07% |
| Week 3 | $0.6518 | $0.7395 | $0.8391 | -0.10% |
| Week 4 | $0.639 | $0.7393 | $0.8553 | -0.14% |
| Week 5 | $0.6278 | $0.739 | $0.8699 | -0.17% |
| Week 6 | $0.6179 | $0.7388 | $0.8832 | -0.21% |
| Week 7 | $0.609 | $0.7385 | $0.8957 | -0.24% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Tenaya Therapeutics, Inc. is a clinical-stage biotechnology company that discovers, develops, and delivers therapies for heart disease in the United States. Its lead product candidates include TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy that is in Phase 1b/2 clinical trial; TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy, which is in Phase 1b/2 clinical trial; and TN-301, a small molecule histone deacetylase-6 for heart failure with preserved ejection fraction that is in phase 1 clinical trial.
The asset is Tenaya Therapeutics, Inc. (TNYA), trading at $0.789 with a market cap of $171.21M and a rank of 3756.
A major floor 23.5% below — a decisive break under it would weaken the trend.
The nearest floor, 5.4% below — buyers have tended to step in here.
The nearest ceiling, 24.3% above — a clean break opens room to run.
A major ceiling 36.0% above — clearing it would confirm fresh momentum.
Key TNYA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TNYA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.7502 | Sell | $0.752 | Sell |
| MA 10 | $0.7731 | Sell | $0.7691 | Sell |
| MA 20 | $0.8158 | Sell | $0.7826 | Sell |
| MA 50 | $0.7767 | Sell | $0.783 | Sell |
| MA 100 | $0.7742 | Sell | $0.796 | Sell |
| MA 200 | $0.9033 | Sell | $0.8787 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 41.20 | Neutral |
| Stoch RSI (14) | 8.38 | Buy |
| CCI (20) | -115.27 | Sell |
| Williams %R (14) | -96.15 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -12.22 | Sell |
| Bollinger %B (20,2) | 0.13 | Neutral |
| Stochastic %K (14) | 3.85 | Buy |
| TRIX (15) | 0.07 | Buy |
| Awesome (5,34) | -0.03 | Sell |
| Ultimate (7,14,28) | 26.79 | Buy |
| Momentum (10) | -0.08 | Sell |
| Aroon Osc (25) | 28.00 | Buy |
| Hull MA (9) | 0.73 | Buy |
| ADX (14) | 13.14 | Neutral |
| ATR (14) | 0.02 | Info |
The current price is $0.789 and the 30-day range runs from $0.6368 to $0.9776. Technicals show a bearish sentiment with RSI(14) at 50. The stock sits near the 50-day simple moving average of $0.7971 and the 200-day simple moving average at $0.942. Support stands at $0.68 and resistance at $0.92.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.55 | $0.7403 | $0.8919 | 0% | Neutral | |
| $0.6668 | $0.8367 | $1.11 | +13% | Neutral | |
| $0.676 | $0.8728 | $1.20 | +18% | Neutral | |
| $0.6449 | $0.8524 | $1.21 | +15% | Neutral | |
| $0.7106 | $0.9591 | $1.40 | +30% | Bullish | |
| $0.7887 | $1.08 | $1.61 | +47% | Bullish | |
| $0.9375 | $1.31 | $1.99 | +77% | Bullish | |
| $1.02 | $1.46 | $2.25 | +97% | Bullish | |
| $0.984 | $1.42 | $2.23 | +92% | Bullish | |
| $1.03 | $1.50 | $2.39 | +103% | Bullish | |
| $1.52 | $2.39 | $4.05 | +223% | Bullish | |
| $2.12 | $3.74 | $6.94 | +406% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.55 | $0.7403 | $0.8677 | +0.00% |
| September 2026 | $0.6105 | $0.7222 | $0.8784 | -2.44% |
| October 2026 | $0.6187 | $0.737 | $0.9062 | +2.04% |
| November 2026 | $0.6067 | $0.7267 | $0.9014 | -1.39% |
| December 2026 | $0.5925 | $0.7134 | $0.8919 | -1.84% |
Click any year to see its month-by-month TNYA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Tenaya Therapeutics, Inc.'s 2026 outlook centres on $0.7403, within a $0.55 to $0.8919 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, TNYA could reach as high as $1.11, with a base case around $0.8367 and support toward $0.6668 — roughly +13% from $0.7403. Price action looks broadly range-bound.
Expect TNYA to range from $0.676 to $1.20 through 2028. The $0.8728 average target implies a +18% move from current prices. That is up +4% on the projected 2027 average. A consolidation phase looks the most probable path here.
The TNYA price prediction for 2029 points to an average of $0.8524 (low $0.6449, high $1.21) — a potential gain of +15% on today's $0.7403. Price action looks broadly range-bound.
In 2030, TNYA is projected to trade between $0.7106 and $1.40, averaging $0.9591 — a potential gain of +30% from today's $0.7403. That is up +13% on the projected 2029 average. Buyers look set to stay in control over this stretch.
Tenaya Therapeutics, Inc.'s 2031 outlook centres on $1.08, within a $0.7887 to $1.61 range. That is up +13% on the projected 2030 average. That marks a +47% change versus current levels. Momentum favours further upside here.
By 2032, TNYA could reach as high as $1.99, with a base case around $1.31 and support toward $0.9375 — roughly +77% from $0.7403. Buyers look set to stay in control over this stretch.
Expect TNYA to range from $1.02 to $2.25 through 2033. The $1.46 average target implies a +97% move from current prices. That is up +11% on the projected 2032 average. Momentum favours further upside here.
The TNYA price prediction for 2034 points to an average of $1.42 (low $0.984, high $2.23) — a potential gain of +92% on today's $0.7403. Buyers look set to stay in control over this stretch.
In 2035, TNYA is projected to trade between $1.03 and $2.39, averaging $1.50 — a potential gain of +103% from today's $0.7403. That is up +6% on the projected 2034 average. Momentum favours further upside here.
Tenaya Therapeutics, Inc.'s 2040 outlook centres on $2.39, within a $1.52 to $4.05 range. That is up +59% on the projected 2035 average. That marks a +223% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, TNYA could reach as high as $6.94, with a base case around $3.74 and support toward $2.12 — roughly +406% from $0.7403. Momentum favours further upside here.
Investing $1,000 in TNYA today (≈ 1,350.803728 TNYA) could be worth
$5,058.18
+$4,058.18 (+406%) by 2050 · US Dollar
Based on the average projected TNYA price of $3.74 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TNYAwould be worth at today's price.
$1,000 invested in TNYA on Jul 31, 2025 (≈ 1,479.289943 TNYA) would be worth
$1,095.12
+$95.12 (+9.5%) today · 1.10× · US Dollar
Based on a TNYA entry price of $0.676 vs. today's $0.7403.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.775 | $955.23 | -4.5% |
| 1 month ago | $0.746 | $992.36 | -0.8% |
| 3 months ago | $0.706 | $1,048.58 | +4.9% |
| 6 months ago | $0.902 | $820.73 | -17.9% |
| 1 year ago | $0.676 | $1,095.12 | +9.5% |
| All time (5.0y) ago | $17.23 | $42.97 | -95.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TNYA forecast.
Our base-case forecast reaches $1.50 around 2035.
Implied market cap at $1.50: $325.5M
Forecasts show a multi-year bullish trajectory. For 2026 the average is $0.789 with a min of $0.55, a max of $0.9582, and ROI 0; sentiment is NEUTRAL. By 2030 the average rises to $0.9779 with a max of $1.48 and ROI 23.9% while sentiment is BULLISH.
In 2031 the average is $1.09 with a max of $1.68 and ROI 37.8%; in 2032 the average is $1.34 with a max of $2.12 and ROI 70.3%. The path continues higher through 2033 (avg $1.50, max $2.42, ROI 90.2%), 2034 (avg $1.41, max $2.31, ROI 78.6%), and 2035 (avg $1.51, max $2.52, ROI 91.4%). By 2040 the average price reaches $2.35 with a max of $4.21 and ROI 198.4%, and by 2050 the average is $3.61 with a max of $7.14 and ROI 357.5%, all with a BULLISH sentiment.
These are estimates and not guarantees, and actual results may differ due to market and clinical development risks.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $0.9779 with a min of $0.7013 and a max of $1.48; ROI is 23.9%, and sentiment is BULLISH.
Long-term forecasts imply a bullish path from 2030 onward, with 2040 avg $2.35 and 2050 avg $3.61 and ROIs of 198.4% and 357.5%, respectively; near-term 2026-2029 show neutral to moderate upside.
Yes. The forecast shows a 2030 max of $1.48 and a 2031 max of $1.68, with continued upside in 2032 and beyond, indicating the potential to reach and exceed $1.
The current price is $0.789.
The market cap is $171.21M.
Tenaya Therapeutics, Inc. Community Discussion
0Share your Tenaya Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.